Journals / Tıp Araştırmaları Dergisi / 2010 / Cilt: 8 - Sayı: 1

Prognostic factors and retrospective analysis of our cases with breast cancer

Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi

Pages
9–14
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We aimed to analyse the prognostic factors including the age, tumor grade and stage, histopathologic type , performed surgical procedures, number of excised lymph nodes and radio / chemotherapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Breast cancer is the 3rd cause of death in women among worldwide following lung and colon cancers.
📊
Key Findings & Data:In this retrospective review of the charts, 56 patients operated for breast cancer in General Surgery Training Clinic of Adana Numune Hospital between January 1997 and December 2003.
💡
Conclusion & Impact:We aimed to analyse the prognostic factors including the age, tumor grade and stage, histopathologic type , performed surgical procedures, number of excised lymph nodes and radio / chemotherapy.
🔬Design:Review & Systematic Survey
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Breast cancer is the 3rd cause of death in women among worldwide following lung and colon cancers. In this retrospective review of the charts, 56 patients operated for breast cancer in General Surgery Training Clinic of Adana Numune Hospital between January 1997 and December 2003. We aimed to analyse the prognostic factors including the age, tumor grade and stage, histopathologic type , performed surgical procedures, number of excised lymph nodes and radio / chemotherapy.

Özet

Kadınlarda meme kanseri akciğer ve kolorektal kanserlerden sonra 3. en sık ölüm nedenidir. Çalışmamızın amacı, Adana Numune Hastanesi Genel Cerrahi Kliniğinde Ocak 1997 – Aralık 2003 tarihleri arasında ameliyat edilen meme kanserli kadın hastaların retrospektif dosya kayıtlarının incelenmesinde, sağ kalım üzerinde etkili olan yaş, tümörün evresi, çapı, histolojik tipi, uygulanan ameliyat tipi, metastatik aksiller lenf nodlarının sayısı ile radyo/kemoterapi gibi prognostik faktörleri belirlemektir.

🔖

Cite This Article

ÖZKAN, S., BÜYÜKDOĞAN, M. (2010). Prognostic factors and retrospective analysis of our cases with breast cancer. Tıp Araştırmaları Dergisi, Cilt: 8 - Sayı: 1, 9–14. https://ajindex.com/articles/361698

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Spratt JS, Donegan WL, Sigdestad CP. Epidemiology and etiology.In Donegan WL,Spratt JS,eds. Cancer of the breast. Philadelphia: WB Saunders, 1995: 116-141
  2. The Breast-Comprehensive Management of Benign and Malignant Disorder, 3rd EditionKirby I. Bland and Edward M. Copeland III, Eds., Philadelphia, PA: Saunders, an imprint of Elsevier Science, 2003, vol. 1: 842 pages, 456; vol. 2: 784 3. Winchester DP. Breast cancer in young women. In Lopez MJ,ed. Special problems in breast cancer therapy. The Surgical Clinics of North America. Philadelphia: WB Saunders 1996; 76(2): 279-287
  3. Crowe JP, Gordon NH, Shenk PR,et al. Age does not predict breast cancer outcome. Arch Surg 1994;129:483-488
  4. Caleffi M, Fentiman IS, Birkhead BG. Factors at presentation influencing the prognosis in breast cancer. Eur J Cancer Clin Oncol 1989; 25:51-56
  5. Cuttler SJ, Black MM, Mork T, et al. Further observations on prognostic factors in cancer of the female breast. Cancer 1969; 24: 653-657
  6. Williams MR, Hinton CP, Todd JH, et al. The prediction of local and regional recurrence after simple mastectomy for operable breast cancer. Br J Surg 1985; 72:721-723
  7. Veronese SM, et al. Proliferation index as a prognostic marker in breast cancer. Cancer 1993; 71: 3926-3931
  8. Locker AP, Horrocks C, Gilmour AS,et al. Flow cytometric and histological analysis of ductal carcinoma in situ of the breast. Br J Surg 1990; 77: 564-567
  9. Hastrich DJ, et al. Comparison of radioligant assay and immunostaining for epidermal growth factor receptor in human breast cancer. Br J Surg 1994; 81: 853-855
  10. Pujol P, et al. A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer 1993; 71: 2006-2012
  11. Isola JJ, et al. Elevated c-erB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer. Cancer 1994; 73: 652-658
  12. Peyrat JP, et al. Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer. Lancet 1995; 345: 621-622
  13. Lauria L,et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 1995; 76: 1772-1778
  14. Gaffney EV,et al. Relationship between low estrogen receptor values and other prognostic factors in primary breast tumors. Surgery 1995; 117: 241-246
  15. Langlands AO, Prescott RJ, Hamilton T. A clinical trial in the management of operable cancer of the breast